ESC Professional Premium Access

What the cardiologist must know: glucose-lowering medication after myocardial infarction in hospital and after discharge

Event: ESC Congress 2022
Topic: Risk Factors and Prevention
Session type: Official Joint Session
Date: 26 August 2022
Time: 16:30 - 17:30

Congress Session

Become an ESC Professional member to access this resource

Become a member

Already a member? Sign in

4 presentations in this session

Glucose-lowering medication after myocardial infarction: case presentation.

Speaker: Doctor G. Ferrannini (Stockholm, SE)
Thumbnail

Glucose-lowering medication after myocardial infarction: how I would treat.

Speaker: Professor A. Avogaro (Padova, IT)
Thumbnail

Glucose-lowering medication after myocardial infarction: how I did treat.

Speaker: Doctor G. Ferrannini (Stockholm, SE)
Thumbnail

Take-home messages: glucose-lowering medication after myocardial infarction in hospital and after discharge.

Speaker: Doctor P. Ueda (Stockholm, SE)
Speaker: Professor A. Tsapas (Thessaloniki, GR)
Thumbnail

5 speakers from this session

Doctor Giulia Ferrannini

Karolinska Institute, Stockholm (Sweden)
2 presentations
0 follower

Professor Angelo Avogaro

PADOVA HOSPITAL, Padova (Italy)
5 presentations
0 follower

Doctor Giulia Ferrannini

Karolinska Institute, Stockholm (Sweden)
2 presentations
0 follower

Doctor Peter Ueda

Karolinska Institute, Stockholm (Sweden)
2 presentations
0 follower

Professor Apostolos Tsapas

Aristotle University of Thessaloniki, Thessaloniki (Greece)
2 presentations
0 follower

This platform is supported by

logo Novo Nordisk